Wellington Management Group
TRVI icon

Wellington Management Group’s Trevi Therapeutics TRVI Stock Holding History

Wellington Management Group’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Buy
5,684,592
+495,504
+10% +$7.21M 0.02% 534
2026
Q1 		$61.9M Buy
5,189,088
+1,785,098
+52% +$20M 0.01% 667
2025
Q4 		$42.6M Buy
3,403,990
+150,102
+5% +$1.73M 0.01% 777
2025
Q3 		$29.8M Buy
3,253,888
+3,081,906
+1,792% +$23.1M 0.01% 882
2025
Q2 		$941K Buy
171,982
+44,530
+35% +$277K ﹤0.01% 1733
2025
Q1 		$802K Buy
+127,452
New +$608K ﹤0.01% 1752

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Wellington Management Group's TRVI Position: Q2 2026 in Review

Wellington Management Group increased its Trevi Therapeutics (TRVI) stake by 9.5% in Q2 2026, buying an estimated $7.21M and bringing the position to 5,684,592 shares worth $106M. The position accounts for 0.02% of the portfolio, ranked #534.

Wellington Management Group first reported a position in TRVI in Q1 2025 and has held it in 6 quarters since. 218 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Wellington Management Group held 5,684,592 shares of Trevi Therapeutics worth $106M as of Q2 2026.
  • Wellington Management Group bought 495,504 Trevi Therapeutics shares in Q2 2026, an estimated $7.21M.
  • Trevi Therapeutics made up 0.02% of Wellington Management Group's portfolio in Q2 2026, its #534 holding.
  • Wellington Management Group first reported a position in Trevi Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 218 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.